Bioengineering extracellular vesicles for enhanced therapeutic functionality and clinical potential in the...

Area of Science:

• Cardiovascular Medicine
• Regenerative Medicine
• Biotechnology

Background:

• Cardiovascular diseases (CVDs) are a major global health burden, with current treatments facing limitations like adverse effects and donor shortages.
• Extracellular vesicles (EVs) are emerging as a potent therapeutic tool for cardiovascular conditions due to their inherent properties.
• Existing therapies for myocardial infarction (MI), heart failure (HF), and atherosclerosis (AS) have significant challenges.

Purpose of the Study:

• To review the complex interactions between EVs and the cardiovascular system.
• To highlight the regenerative potential of EVs in cardiovascular repair.
• To discuss the clinical applications of native and bioengineered EVs in cardiovascular health.

Main Methods:

• Literature review focusing on extracellular vesicles (EVs) and cardiovascular diseases (CVDs).
• Analysis of EV composition, intercellular communication, and immune regulatory roles.
• Examination of bioengineered EVs for enhanced therapeutic potential.

Main Results:

• EVs facilitate intercellular communication, modulate the cardiovascular microenvironment, and regulate immune responses.
• EVs possess significant regenerative capacity for cardiovascular repair.
• Bioengineered EVs offer improved targeting specificity and controlled cargo delivery for therapeutic applications.

Conclusions:

• EVs represent a promising therapeutic platform for cardiovascular medicine, offering novel strategies for repair and regeneration.
• Bioengineered EVs hold significant potential for treating cardiovascular diseases with enhanced efficacy and specificity.
• Further research into EVs can advance cardiovascular homeostasis, remodeling, metabolism, and regeneration.